Bain considers options for Waystar: Bloomberg


Bain Capital is weighing options, including a sale, of Waystar, a healthcare technology company, Bloomberg reported. Bain has held early stage discussions about a potential sale that could value Waystar at more than $3 billion, the story said.

Do you want exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more? Get your FREE trial to Buyouts! Or subscribe now!